•
Sep 30, 2018

Denali Therapeutics Q3 2018 Earnings Report

Total Revenue
$1.2M
EPS
-$0.38
Previous year: -$0.265
+43.4%
Gross Profit
-$29.1M
Previous year: -$18.5M
+57.3%
Cash and Equivalents
$43.7M
Free Cash Flow
-$35.7M
Total Assets
$544M

Denali Therapeutics

Denali Therapeutics